CompletedNot Applicable

Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

China3,060 participantsStarted 2012-01

Plain-language summary

This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.

Who can participate

Age range12 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Atrioventricular Nodal Reentrant Tachycardia * Atrioventricular Reentrant Tachycardia Exclusion Criteria: * Atrial Tachycardia * Organic supraventricular tachycardia

What they're measuring

Procedural success rate

Timeframe: one year

Trial details

NCT IDNCT03042078

SponsorTongji Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-02

View on ClinicalTrials.gov More Paroxysmal Supraventricular Tachycardia trials